Call us at (860) 830-7838
Behavioral Wellness Clinic

BEHAVIORAL WELLNESS & MENTAL HEALTH SERVICES IN EASTERN CONNECTICUT


Psychedelic Medicine

MDMA-Assisted Psychotherapy for PTSD

Dr. Monnica Williams and Sara Reed are part of an FDA approved randomized controlled trial of MDMA-assisted psychotherapy for PTSD that is taking place at the University of Connecticut Health Center (UCHC) in the Department of Psychiatry, in Farmington, Connecticut. This is a cutting-edge treatment for people who have not responded to traditional therapies for PTSD.

A Paradigm Shift in Psychiatric Care

Dr. Monnica Williams is the principal investigator on the phase 3 multisite trial for MDMA-assisted psychotherapy for PTSD, taking place at UCHC. Sara's role in the study includes screening potential participants, coordinating medical tests, and providing psychotherapy. Both have received extensive training in the delivery of MDMA-assisted psychotherapy through the Multidisciplinary Association for Psychedelic Studies (MAPS) with study director Dr. Michael Mithoefer and many other experts on the MAPS team. Sara is also certified in internal family systems therapy and is familiar with Holotrophic Breathwork. Therapists at BWC are available to assist people who are working to integrate and resolve experiences involving non-ordinary states of consciousness.

A group of mental health professionals.

Doctoral student Terence Ching, research assistant Jamilah George, and therapist Sara Reed participate in a mental health training in New York for the MDMA-assisted PTSD clinical trial at UConn Health Center.

Media Coverage

Hellerman, C. (2016, December 1). Using Ecstasy to treat PTSD: I felt like my soul snapped back into place. PBS Newshour.

Williams, M. (2016, October 6). Column: White people don't understand the trauma of viral police-killing videos. PBS Newshour.

Recent Papers & Presentations

Ching, T. H. W., Williams, M. T., Kisicki, Reed, S. J., & George, J. (2017, November). MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD: MAPS-Sponsored Phase 2 Findings & Cultural Considerations for Phase 3 Trials. Poster to be presented at the 51st Annual Convention of the Association of Behavioral and Cognitive Therapies, San Diego, CA.

Williams, M. T., & Leins, C. (2016). Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy. Multidisciplinary Association for Psychedelic Studies (MAPS) Bulletin, 26(1), 32-37.

BEHAVIORAL WELLNESS CLINIC

6-D LEDGEBROOK DRIVE
SECOND FLOOR
MANSFIELD CENTER, CT 06250
OFFICE: (860) 830-7838
FAX: (860) 477-0656

 
CLINICAL DIRECTOR: MONNICA WILLIAMS, PHD
OFFICE MANAGER: JASMINE FAIRFAX
BUSINESS MANAGER: MATTHEW JAHN